Canopy Growth (CGC) Long-Term Investments (2018 - 2025)
Canopy Growth's (CGC) quarterly Long-Term Investments came in at $111.3 million in Q4 2025, up 211.87% year-on-year from $35.7 million in Q4 2024, and down 19.02% quarter-over-quarter from $137.4 million in Q3 2025.
Canopy Growth (CGC) Long-Term Investments (2018 - 2025) Analysis & Trends
Canopy Growth has disclosed Long-Term Investments across 8 years of filings, most recently posting $111.3 million for Q4 2025.
- Long-Term Investments for Q4 2025 came in at $111.3 million, up 211.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $111.3 million (up 211.87% YoY), and the FY2025 annual result was $125.4 million, down 61.38% from the prior year.
- Long-Term Investments came in at $111.3 million for Q4 2025 at Canopy Growth, down from $137.4 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $324.8 million in Q1 2024 to a low of $79009.9 in Q1 2021.
- The 5-year median for Long-Term Investments is $66.0 million (2023), against an average of $86.8 million.
- Across the five-year window, Long-Term Investments slumped 99.84% in 2021 and soared 692.78% in 2024, its largest moves.
- Canopy Growth's Long-Term Investments stood at $79009.9 in 2021, then soared by 34399.48% to $27.3 million in 2022, then declined by 11.07% to $24.2 million in 2023, then jumped by 47.17% to $35.7 million in 2024, then jumped by 211.87% to $111.3 million in 2025.
- The last three Long-Term Investments figures came in at $111.3 million (Q4 2025), $137.4 million (Q3 2025), and $116.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.90 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 111.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 111.26 Mn |
| Sep 30, 2025 | 137.38 Mn |
| Jun 30, 2025 | 116.85 Mn |
| Mar 31, 2025 | 125.43 Mn |
| Dec 31, 2024 | 35.67 Mn |
| Sep 30, 2024 | 99.97 Mn |
| Jun 30, 2024 | 110.16 Mn |
| Mar 31, 2024 | 324.77 Mn |
| Dec 31, 2023 | 24.24 Mn |
| Sep 30, 2023 | 57.44 Mn |
| Jun 30, 2023 | 74.48 Mn |
| Mar 31, 2023 | 40.97 Mn |
| Dec 31, 2022 | 27.26 Mn |
| Sep 30, 2022 | 55.21 Mn |
| Jun 30, 2022 | 47.06 Mn |
| Mar 31, 2021 | 79,009.91 |
| Dec 31, 2020 | 13.03 Mn |
| Sep 30, 2020 | 19.26 Mn |
| Jun 30, 2020 | 42.30 Mn |
| Mar 31, 2020 | 49.11 Mn |